Profile: Biocon is a fully integrated healthcare company that delivers biopharmaceutical solutions. Our products are useful in the field of oncology, nephrology, diabetes and autoimmune diseases. Our products include human insulin, insulin lispro, insulin aspart and insulin glargine. Our product filgrastim also known as granulocyte colony stimulating factor (GCSF) is a naturally occurring growth factor or hormone that is primarily responsible for the proliferation of neutrophils or white blood cells. During cancer chemotherapy, the number of cells responsible for expressing this hormone gets reduced, making filgrastim supplementation necessary. This hormone is harvested by inserting the human GCSF gene into escherichia coli (E coli). The product thus obtained is identical to the protein produced naturally, except that it is not glycosylated. It is used in the treatment of neutropenia associated with myelosuppressive chemotherapy.